Document is current
Any future updates will be listed below
-
Authors
Zhang, Wuji https://orcid.org/0000-0001-7460-4956
Chua, Brendon Y.
Selva, Kevin J.
Kedzierski, Lukasz
Ashhurst, Thomas M. https://orcid.org/0000-0001-7269-7773
Haycroft, Ebene R. https://orcid.org/0000-0002-5059-3030
Shoffner-Beck, Suzanne K. https://orcid.org/0000-0003-0010-6318
Hensen, Luca
Boyd, David F. https://orcid.org/0000-0003-1383-4939
James, Fiona https://orcid.org/0000-0003-0469-5666
Mouhtouris, Effie
Kwong, Jason C.
Chua, Kyra Y. L. https://orcid.org/0000-0001-8826-7137
Drewett, George
Copaescu, Ana
Dobson, Julie E.
Rowntree, Louise C.
Habel, Jennifer R. https://orcid.org/0000-0003-0380-1527
Allen, Lilith F.
Koay, Hui-Fern https://orcid.org/0000-0002-3236-9609
Neil, Jessica A. https://orcid.org/0000-0003-2824-3701
Gartner, Matthew J.
Lee, Christina Y. https://orcid.org/0000-0002-9393-2178
Andersson, Patiyan
Khan, Sadid F.
Blakeway, Luke
Wisniewski, Jessica https://orcid.org/0000-0002-9923-6579
McMahon, James H.
Vine, Erica E. https://orcid.org/0000-0003-4441-3301
Cunningham, Anthony L. https://orcid.org/0000-0002-6744-5667
Audsley, Jennifer https://orcid.org/0000-0001-6322-3197
Thevarajan, Irani
Seemann, Torsten
Sherry, Norelle L. https://orcid.org/0000-0002-7789-8360
Amanat, Fatima https://orcid.org/0000-0002-8029-8227
Krammer, Florian https://orcid.org/0000-0003-4121-776X
Londrigan, Sarah L. https://orcid.org/0000-0003-0989-4971
Wakim, Linda M. https://orcid.org/0000-0003-1752-9579
King, Nicholas J. C. https://orcid.org/0000-0002-3877-9772
Godfrey, Dale I. https://orcid.org/0000-0002-3009-5472
Mackay, Laura K. https://orcid.org/0000-0002-8496-6632
Thomas, Paul G. https://orcid.org/0000-0001-7955-0256
Nicholson, Suellen https://orcid.org/0000-0001-6585-7150
Arnold, Kelly B. https://orcid.org/0000-0003-4756-7461
Chung, Amy W. https://orcid.org/0000-0003-0020-9704
Holmes, Natasha E.
Smibert, Olivia C.
Trubiano, Jason A.
Gordon, Claire L. https://orcid.org/0000-0001-5172-4728
Nguyen, Thi H. O. https://orcid.org/0000-0002-9294-7693
Kedzierska, Katherine https://orcid.org/0000-0001-6141-335X
-
Funding
Funding for this research was provided by:
Department of Health | National Health and Medical Research Council
- License Information
-
More Information
Article History
Received: 11 August 2021
Accepted: 11 April 2022
First Online: 19 May 2022
Competing interests
: The Icahn School of Medicine at Mount Sinai has filed patent applications relating to SARS-CoV-2 serological assays (U.S. Provisional Application Numbers: 62/994,252, 63/018,457, 63/020,503 and 63/024,436) and NDV-based SARS-CoV-2 vaccines (U.S. Provisional Application Number: 63/251,020) which list Florian Krammer as co-inventor. Fatima Amanat is also listed on the serological assay patent application as co-inventors. Patent applications were submitted by the Icahn School of Medicine at Mount Sinai. Mount Sinai has spun out a company, Kantaro, to market serological tests for SARS-CoV-2. Florian Krammer has consulted for Merck and Pfizer (before 2020), and is currently consulting for Pfizer, Third Rock Ventures, Seqirus and Avimex. The Krammer laboratory is also collaborating with Pfizer on animal models of SARS-CoV-2. Dale Godfrey is listed as co-inventor on patent applications relating to SARS-CoV-2 vaccines and lateral flow assay for neutralizing antibodies. Paul Thomas is on the SAB of Immunoscape and Cytoagents and has consulted for JNJ. Paul Thomas has received travel support and/or honoraria from Illumina and 10X Genomics and has patents related to TCR discovery and expression. All authors declare no other competing interests.
